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Thrombocytopenia is a major hematological disorder
observed in patients with liver cirrhosis (LC). The condition
is primarily attributed to hypersplenism, which is accompa-
nied by an increased sequestration and accelerated destruc-
tion of platelets in the pathologically enlarged and congested
spleen.1—3 Patients with LC are also frequently subject to
various disorders of the gastric mucosa, and peptic lesions in
the gastroduodenal mucosa have been observed more often
in cirrhotic patients than in controls. Helicobacter pylori
infection is reportedly an important factor in the pathogen-
esis of such cases.4—7 Recently, H. pylori eradication has been
reported as effective for managing H. pylori-positive idio-
pathic thrombocytopenic purpura (ITP). Eradication therapy
is drawing attention in ITP, particularly because this approach
readily increases platelet counts.8,9 We describe herein a
case of H. pylori-related ITP in a patient with LC accompany-
ing hepatitis B. No previous case reports have described
associations between H. pylori-related ITP and cirrhotic
patients.
A 65-year-oldmanwas admitted to our hospital in Decem-
ber 2005 for further evaluation of thrombocytopenia during
his monthly follow-up for LC accompanying hepatitis B,
hypertension and diabetes. Although his platelet count
had been around 5.0  104/ml during his regular follow-up
for liver cirrhosis, his platelet count was extremely
decreased on admission (0.4  104/ml). Physical examina-
tion was unremarkable, without any lymphadenopathy.
Computed tomography (CT) and ultrasonography showed
splenomegaly (spleen index: 14.3 cm  8.7 cm). Testing
for human immunodeficiency virus yielded negative results,
but H. pylori infection was diagnosed based on a positive
urea breath test. Bone marrow aspiration and biopsy
revealed increased megakaryocytes and normal morpholo-
gical appearance. Cytogenetic analysis of marrow cells also
yielded normal results.With these findings, a diagnosis of ITP
accompanying thrombocytopenia due to LC was suggested.
The patient was subsequently started on prednisone (60 mg/
day) along with lamivudine (200 mg/day). His insulin dose
was increased appropriately to control the diabetes. Eradi-
cation therapy against H. pylori (a standard 1-week regimen
containing amoxicillin, clarithromycin and lansoprazole)1201-9712/$32.00 # 2006 International Society for Infectious Diseases.was also started. His platelet count rose to 4.3  104/ml
on day 7, but fell to 0.8  104/ml on day 15. The dosage of
oral prednisone was reduced by half on day-21 because the
steroid did not seem to increase the effect. By one month
following initiation of treatment, his platelet count had
risen to around 3.0  104/mL, and the patient was dis-
charged on 10 mg/day of prednisone in February 2006. On
discharge, the 13C-urea breath test yielded negative
results. His platelet count three months later ranged from
4.0  104/mL to 5.0  104/mL, although oral prednisone and
lamivudine had been reduced to 5 mg/day and 100 mg/day,
respectively. At the eight-month follow-up, his platelet
count remained around 4.0  104/mL to 5.0  104/mL with-
out the use of prednisone. Lamivudine was administered at
100 mg every three days and as of the time of writing, no
reactivation of chronic hepatitis B virus infection has been
identified.
Many studies have reported the presence of H. pylori
infection with autoimmune diseases such as chronic thyr-
oiditis, Sjo¨gren’s disease, rheumatoid arthritis, and ITP,
where H. pylori infection is indicated as a possible cause.10
Among these, ITP is drawing particular attention because
the clinical benefit and efficacy of eradication therapy
against H. pylori has been demonstrated.8,9 The present
case highlights an interesting manifestation in cirrhotic
patients, and the true frequency of H. pylori-related ITP
cases in cirrhotic patients might be significantly higher than
the low prevalence suggested by the paucity of reported
cases. This association would also greatly facilitate under-
standing of the mechanisms underlying H. pylori-related
ITP.
In conclusion, the possible association between thrombo-
cytopenia with LC and H. pylori-related ITP should be kept in
mind, particularly when thrombocytopenia steadily develops
during the clinical course.
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tuberculosis (3D reconstruction).Tuberculosis and tracheal bronchus
Anomalies of the lung and bronchial tree are diagnosed with
increasing frequency as a result of refinements in modern
imaging.1 Most of these are rare and almost always asympto-
matic congenital malformations. Some of these anomalies
are found during investigations in patients with respiratory
diseases.
Tuberculosis is one of the ten main causes of death in the
developingworld; pulmonary tuberculosis is themost common
clinical form.2 Even with completion of appropriate treat-
ment, this disease can produce progressive destruction of lung
tissue, and cavitation is a common sequela. Following cavita-
tion,many patients can go on to develop fungal ball, recurrent
pneumonia and hemoptysis across variable time intervals;
some may remain asymptomatic for life.3 We report below,
the case of a patient who had tuberculosis 15 years ago and
received appropriate chemotherapy. After 15 asymptomatic
years, she presented with acute hemoptysis and further inves-
tigation led to a diagnosis of bronchial anomaly.
A 41-year-old female patient presented after an episode
of hemoptysis in July 2006. The patient had had pulmonary
tuberculosis at 12 years of age and again at 26 years of age;
both episodes had been adequately treated and she had
experienced no other illness or pulmonary symptoms since
then. She presented with a bronchial sound in the right upper
quadrant. Plain chest radiography showed a right-apical
cavitation. Three specimens of sputum were smear- and
culture-negative. Computed tomography imaging revealed
an extensive right upper lobe cavitation without signs of
active disease and a tracheal bronchus arising distal to the
origin of the upper lobe bronchus, so-called posteparterial
(Figure 1).
Congenital anomalies most often confused with tuber-
culosis are unilateral lung hypoplasia, bronchogenic cystsand tracheal bronchus with an anomalous lobe.4 Although
congenital anomalies are often confused with tuberculosis,
our case describes a tracheal bronchus in a patient with a
large persisting tuberculosis cavity. To-date only three
cases of this association have been reported in the litera-
ture.5,6
Tracheal bronchus is not such a rare event and its associa-
tion with tuberculosis is probably underestimated. Tubercu-
losis and other infections can occur as a result of insufficient
drainage of the involved bronchi.6 The identification of this
anomaly is very important in order for the physician to
perform an adequate bronchoscopy, to avoid difficulties in
placement ormalpositioning of an endotracheal tube, and for
surgical planning when a resection is required.
